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SUMMARY 
 
Snail1 transcriptional factor is essential for triggering epithelial-to-mesenchymal 
transition (EMT) and inducing tumor cell invasion. We report here an additional, EMT-
independent action of Snail1 on tumor invasion: its expression in cancer-associated 
fibroblasts is necessary for enhancement by these cells on epithelial cells tumor 
invasion. Snail1 expression in fibroblast requires signals derived from tumor cells such 
as TGF-; reciprocally, in fibroblasts Snail1 organizes a complex program that favors 
collective invasion of epithelial cells at least in part by the secretion of diffusible 
signaling molecules, such as prostaglandin E2. The capability of human or murine 
tumor-derived cancer associated fibroblasts to promote tumor invasion is associated to 
Snail1 expression and obliterated by Snail1 depletion. In vivo experiments show that 
Snail1 depletion in mice prevents the invasion of breast tumors and epithelial tumor 
cells co-xenografted with Snail1-depleted fibroblasts originate tumors with lower 
invasion than those transplanted with control fibroblasts. Therefore, these results 
demonstrate that the role of Snail1 in tumor invasion is not limited to EMT but 
dependent on its expression in stromal fibroblasts where it orchestrates its activation 
and the crosstalk with epithelial tumor cells.  Moreover, they point to the interference of 
Snail expression as a promising target for preventing the action of stromal fibroblasts 
on tumor progression.            
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INTRODUCTION 
Epithelial to mesenchymal transition is a process characterized by the loss of epithelial 
features and the gain of mesenchymal traits. This process widely described during 
embryo development provides the cells with higher migration, besides inducing other 
cancer hallmarks such as resistance to apoptotic insults or unlimited replication. As 
consequence cells that have undergone an EMT present a higher capability to invade 
both in vitro and in vivo (Thiery et al, 2009). However, the precise contribution of EMT 
to tumor invasion in vivo is still a matter of discussion since the number of tumor cells 
displaying mesenchymal characteristics is low in human tumors (Tarin et al, 2005). In 
many cases tumor cells exhibit a collective invasion maintaining epithelial 
characteristics (Friedl and Alexander, 2011).  
Molecularly EMT is associated with the down-regulation of E-cadherin (CDH1) gene 
expression and the up-regulation of mesenchymal markers (Thiery et al., 2009; Garcia 
de Herreros and Baulida, 2012). Among the several CDH1 transcriptional repressors 
induced during EMT Snail1 has received a particular attention since is the first one to 
be temporally induced and is required for the induction of other CDH1 repressors, such 
as Zeb1/ 2; consequently; Snail1 transfection promotes an extensive EMT (Garcia de 
Herreros and Baulida, 2012). Snail1 is a transcriptional factor that recruits to CDH1 
promoter co-repressors such as histone deacetylases 1 and 2 (Peinado et al., 2004), 
Polycomb repressive complex 2 and G9a histone 3 lysine methylases (Herranz et al, 
2008; Dong et al, 2012) and PRMT5 histone 4 arginine demethylase (Hou et al, 2008). 
However, Snail1 does not act uniquely as repressor since during EMT it is also present 
in the promoters of activated mesenchymal genes such as fibronectin (Stanisavljevic et 
al, 2011). A recent report demonstrates that the activity of Snail1 as repressor or 
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activator relies in its acetylation in lysines 146 and 187 by CREB-binding protein (Hsu 
et al, 2014) since the modification of these residues promotes the Snail1 switch from 
epithelial-repressed to mesenchymal-induced genes. In accordance with this function 
in the activation of mesenchymal genes, Snail1 action is not limited to EMT. Besides 
other effects in embryonic stem cells (Lin et al, 2014), Snail1 is required for a complete 
fibroblast response to PDGF or TGF- since signaling by these factors is severely 
affected by Snail1 genetic depletion (Rowe et al, 2009; Batlle et al, 2013).  
It is now totally accepted that tumoral cells modify their context creating a 
micronvironment, the tumor stroma that provides signals required for the acquisition of 
many cancer hallmarks (Pietras and Ostman, 2010). Among the components of the 
tumor estroma, the cancer-associated fibroblasts (CAFs) have received special 
attention due their capability to support growth and invasion of epithelial cells (Gaggioli 
et al. 2007; Li et al, 2012; Calon et al., 2012; Herrera et al, 2014). When analyzing 
Snail1 expression in tumors we have detected that is mainly present in fibroblasts in 
the tumor stroma of breast and colon tumors (Franci et al., 2009; Stanisavljevic et al, 
2015) and correlates with a bad prognosis even in low-grade tumors. These studies 
agree with recent reports indicating that stromal fibroblasts markers are the best 
indicators of prognosis for colon neoplasms, even in low-grade tumors (Calon et al, 
2015). In this article we have analyzed the cooperation between epithelial and stromal 
cells during tumor invasion. Our results show that the stimulation of epithelial cell 
invasion by mesenchymal cells requires the Snail1-dependent activation of these 
fibroblasts by cytokines released by tumor cells. Activated fibroblast guide the process 
of invasion producing factors, such as prostaglandin E2 (PGE2), capable to cause the 
collective migration of epithelial cells.                
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RESULTS 
Snail1 expression in fibroblasts is required for induction of epithelial cell 
invasion 
As first step to set our cellular model, we analyzed the invasiveness of a panel of 
breast or colon tumor cell lines in Boyden Chambers (Fig S1A). From this panel we 
selected a representative line from both breast or colon showing low (MCF-7 and HT-
29 M6) or high (MDA-MB231 and SW-620) invasion. We analyzed the cooperation 
between cell lines displaying low invasiveness and mesenchymal cells. As cellular 
models of fibroblastic cells we used murine embryo fibroblasts (MEFs) and 
mesenchymal stem cells (MSCs). These cells have been shown to contribute to the 
formation of cancer-associated fibroblasts in the tumor stroma and promote growth and 
progression of tumors (Karnoub et al, 2007; Mishra et al, 2008; Quante et al, 2011). In 
order to specifically analyze the invasion of HT-29 M6, these cells were stably 
transfected with RFP and only cells showing red fluorescence in the lower part for the 
membrane were considered. As shown in Figs 1A and B, co-seeding of HT-29 M6 with 
MSC increased the number of epithelial cells migrating through the matrix. This effect 
was observed both on Matrigel (Figs 1A and B) and Collagen1 (Fig S2A) matrices and 
was inhibited by a general metalloprotease inhibitor, GM6001 (GM) (Galardy et al, 
1994) (Figs S2A and S2B). The stimulation of invasion required a lower number of 
MSCs than epithelial cells: a ratio of 1/10 of MSC with respect to HT-29 M6 cells 
produced a close to maximal effect (Fig S2C). Interestingly MSC deficient in Snail1 (Fig 
S3A) were unable to stimulate epithelial invasion either through Matrigel (Figs 1A and 
B) or Collagen 1 (Fig S2A). 
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These results were also repeated using MEFs either wild-type or depleted in Snail1 
(Fig S3A). Only wild-type cells enhanced HT-29 M6 invasion (Fig 1C); Snail1 KO cells 
did not modify this parameter.  
We have previously shown that Snail1-depletion in MSCs greatly compromises their 
response to TGF- (Batlle et al, 2013). Although the activation of its receptor and early 
responses are not affected, Snail1-depletion prevents later responses to TGF- (Batlle 
et al, 2013). Therefore, we determined if the enhancement in HT-29 M6 invasion 
produced by MSCs was dependent on signaling by this cytokine. As shown in Fig 1B, 
the broadly used TGF- receptor I (TBR) inhibitor SB505124 (SB) (daCosta Byfield et 
al, 2004) totally prevented the action of MSCs on HT-29 M6 invasion, although it did 
not significantly affect basal HT-29 M6 invasion. The release of the cytokine to the cell 
medium was also determined. HT-29 M6 secreted considerably more TGF- than 
MSCs (Fig 1D); no significant differences were observed between the amounts 
produced by wild-type or Snail1 KO cells in these conditions. The co-culture of 
epithelial and mesenchymal cells only showed an additive effect. Therefore, these 
results indicate that in these experiments TGF- is produced mainly by the tumor cells.  
We also determined the effect of TGF and HT-29 M6 on MSCs invasion. Following 
an experimental approach similar to that described in Fig 1A, MSCs were transfected 
with a GFP-expressing plasmid to distinguish them from HT-29 M6.  As shown in Fig 
1E (right), exogenous TGF- remarkably increased MSCs invasion. As expected this 
effect was blocked by addition of the TBR inhibitor SB. An even greater stimulation was 
also observed when HT-29 M6 cells were included in the co-culture; this up-regulation 
was sensitive to the TBR inhibitor SB (Fig 1E, left). Neither TGF- nor HT-29 M6 
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stimulated the migration of Snail1-depleted MSCs (Fig 1E) indicating that Snail1 is 
required for a complete response to TGF-.  
We analyzed the morphological characteristics of the invading co-culture, using 
unlabelled HT-29 M6 and MSCs expressing GFP. As shown in Fig 2, GFP-labelled 
MSCs were observed below HT-29 M6, preceding them and likely leading their 
migration. Epithelial cells invaded collectively although we detected a small change in 
the morphology of the cells placed in the interface; they adopted a more elongated 
phenotype with a basal nuclei opposed to the area of migration. Mesenchymal cells 
exhibited a stretched morphology (Figs 2). Invading HT-29 M6 cells did not show any 
sign of EMT; they did not express Snail1 that was restricted to MSCs, and maintained 
the expression of E-cadherin (Fig 2). Moreover, we did not observe any mesenchymal 
putatively generated from HT-29 M6 since all contained GFP.     
Differently to wild-type cells, MSCs deficient in Snail1 did not invade and remained 
much more associated to the epithelial layer (Fig 2). A similar morphology was 
observed when HT-29 M6 were co-cultured with wild-type MSCs in the presence of the 
TBR inhibitor SB, in accordance with previous results indicating that fibroblast 
activation by TGF- is deficient in Snail1-depleted cells.  As expected this inhibitor, 
decreased the levels of P-Smad2, used as a surrogate marker of TGF-signaling, in 
both mesenchymal and epithelial cells. This staining also indicated that MSCs were 
indeed binding TGF-.  
In order to ascertain the signals triggered by the TGF-/Snail1 axis in MSCs that might 
be involved in HT-29 M6 invasion, we investigated the genes stimulated differently by 
this cytokine TGF- in MSCs wild-type versus Snail1 KO. We compared the global 
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transcriptomes of these two cells lines after incubation with TGF-; 803 genes that 
were regulated by this cytokine in control MSCs showed different levels in TGF--
stimulated Snail1 KO cells (see the full list in GEO repository; accession number 
GSE74058). Among these genes, we selected those genes categorized in cell-cell 
communication, growth factors or extracellular matrix degradation; they are presented 
in Fig S4A. As shown, several metalloproteases, protease inhibitors and growth factors 
were differently expressed. Besides these, we also observed differences in Ptgs2 
(prostaglandin-endoperoxidase synthase 2) also known as cycloxigenase 2 or Cox2, 
an enzyme required for the synthesis of prostaglandins including prostaglandin E2 
(PGE2), a molecule that regulates tumor cell proliferation, invasion, apoptosis and 
angiogenesis (Wang and DuBois, 2010).  
We also determined if this time of treatment with TGF- indeed mimicked the effect of 
co-culture with HT-29 M6, and the levels of these RNAs were stimulated in MSCs by 
HT-29 M6 and altered by Snail1 depletion. We took advantage of the different origin of 
MSCs, murine, and HT-29 M6, human. Expression of Snail1, Mmp13, Pdgfb and Cox2 
was significantly increased in MSCs when HT-29 M6 cells were also co-cultured (Fig 
S4B); the RNA corresponding to another gene involved in PGE2, Ptges2 was not 
increased. We also determined the levels of another enzyme controlling PGE2, 15-
hidroxi prostaglandin dehydrogenase (15-Hpgd) that is negatively controlled by Snail1 
(Mann et al, 2006). 15-Hpgd RNA levels were substantially decreased by co-culture of 
with MSCs with HT-29 M6 (Fig S4B). The mRNAs corresponding to Snail1, Mmp13 
and Cox2 were significantly down-regulated in MSCs KO for Snail1 with respect to 
wild-type MSCs when these cells were co-cultured with HT-29 M6; on the contrary, 15-
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Hpgd was markedly increased (Fig S4B). Levels of Ptges2 and Pdgb were not 
different.   
 
PGE2 secretion by fibroblast regulates epithelial cell invasion 
Since the mRNAs corresponding to two key enzymes controlling PGE2 were altered in 
Snail1 KO cells, we further investigated the relevance of this molecule. First, the levels 
of PGE2 in the cellular medium were determined. Addition of TGF- increased the 
secretion of this prostaglandin by wild-type but not Snail1-deficient MSCs (Fig 3A).  HT-
29 M6 only produce very limited amounts of the cytokine; however, co-culture of both 
cells greatly increased the amount of PGE2 present in the culture medium, an up-
regulation that was sensitive to the TBR inhibitor SB and to the expression of Snail1 in 
MSCs (Fig 3A). Addition of the Cox-2 inhibitor Celecoxib (Penning et al, 1997) also 
remarkably decreased the secretion of PGE2 to the cell co-culture medium (Fig 3A). 
Therefore, we concluded that HT-29 M6-produced TGF- induces PGE2 secretion by 
MSCs in a Snail1-dependent manner. 
We also examined the relevance of PGE2 production by MSCs for HT-29 M6 invasion. 
As shown in Fig 3B, Celecoxib addition reversed the MSCs enhancement of HT-29 M6 
invasion. We also used two other compounds that specifically block PGE2 receptors 
EP2 and EP4, and also Crenolanib, a PDGF antagonist. Addition of the EP4 receptor 
inhibitor L-161,982 (L-161) (Cherukuri et al, 2007) prevented the effect of MSCs on HT-
29 M6 cells; on the contrary, the EP2 receptor inhibitor PF04418949 (PF-044) (af 
Forselles et al, 2011) or Crenolanib (Dai et al, 2013) did not reverse the stimulation.  L-
161 also prevented the stimulation in HT-29 M6 invasion detected when supplementing 
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these cells in the lower chamber of a Boyden Chamber with conditional medium of 
wild-type MSCs (Fig S5A). 
In accordance with these results, PGE2 stimulated HT-29 M6 invasion even in the 
absence of MSCs (Fig 3C); this effect was prevented by addition of L-161 but not of 
PF-044, further indicating that PGE2 signals through the EP4 receptor in HT-29 M6 
cells. Stimulation of invasion by the prostaglandin was dependent on its addition in the 
lower compartment of the Boyden Chamber, suggesting that it was working as a 
chemo-attractant; addition of the same concentration of PGE2 in the upper chamber did 
not enhance invasion (Fig S5B). As expected, PGE2-induced invasion was dependent 
on the action of metalloproteases since it was blocked by a general inhibitor of these 
enzymes (Fig S5B). PDGF-BB addition also increased HT-29 M6 invasion, a 
stimulation that was prevented by Crenolanib (Fig 3C). The effect of this inhibitor 
preventing the action of PDGF but not of MSCs suggests that this factor is not 
contributing to the stimulation by MScs of HT-29 M6 invasion.   
Since inhibition of PGE2 action promoted a remarkable action on HT-29 M6 invasion in 
co-cultures we tried to rescue the lack of stimulation of MSCs KO by the 
supplementation of PGE2. As seen in Figs 3C, PGE2 increased HT-29 M6 invasion in 
co-cultures with MSC (Snail1 KO) although not as much as when directly added to the 
epithelial cells.  
The effect of the inhibitors and PGE2 was also determined on the invasion of MSCs. As 
shown in Fig 3D, Celecoxib, L-161 or Crenolanib did not prevent the up-regulation in 
MSCs invasion caused by co-culture with HT-29 M6. Neither PGE2 nor PDGF-BB 
increased MSCs invasion when added directly to these cells (Fig 3E). In accordance 
with the different effects of PGE2 on HT-29 M6 and MSC, the analysis of the 
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morphology of the co-cultures showed that L-161 did not prevented the migration of 
MSC but it impaired that of HT-29 M6 (Fig S6). Consequently, MSC moved away from 
the epithelial cells that did not follow them.        
We also characterized the invasion of HT-29 M6 promoted by PGE2 addition analyzing 
the RNAs modified by this treatment. Among the 2,190 genes differently expressed 
(see the full list in GEO repository; accession number GSE74058), we detected several 
proteases and factors involved in cell-cell communication (Fig S7A). The up-regulation 
in MMP3 and was verified by RT-PCR (Fig S7B); however, we did not detect any 
significant change in COX2 and CDH1 and only a slight increase in SNAIL1 that was 
not confirmed by Western blot (Fig S7C). 15-Hpgd protein was not modified either. The 
morphology of invading cells was also determined upon PGE2 addition. As observed, 
no phenotypic differences were observed in the cells that invade collectively (Fig S7D).   
The reproducibility of the MSC effects on epithelial cell invasion in other cell lines was 
also determined.  As seen in Fig S8A-D, invasion of intestinal HCT-116 or breast MCF-
7, T47D and SK-BR3 cells was higher in the presence of wild-type MSCs; Snail1 null 
MSCs showed a lower enhancement of this parameter. In all these cases, the effect of 
MSCs was significantly (HCT-116, SK-BR3) or totally (T47D, MCF-7) prevented by 
addition of Celecoxib or L-161 (Fig S8A-D), indicating that it involved PGE2 production 
and signaling. Accordingly, invasion of the four cell lines was stimulated by addition of 
PGE2 (Fig S8E). Curiously, not all the cells showed the same sensitivity to TBR 
inhibitor: contrary to the other cell lines, enhancement of MCF-7 invasion by MSCs was 
not affected by addition of SB (Fig S8C). This result suggests that stimulation of MSCs 
by MCF-7 was not dependent on the action of TGF-.  
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In accordance with the previous results MSCs invasion was up-regulated by co-culture 
by all the epithelial cells tested, thus HCT-116, T47D and MCF-7 (Fig S8F). Different to 
the other two cell lines, that were significantly sensitive to TBR inhibition, MCF-7 
stimulation of MSCs invasion was only very slightly affected by the addition of SB.  
 
Stimulation of tumor cell invasion by cancer-associated fibroblasts is also 
dependent on Snail1 expression 
We also determined if the requirement for Snail1 expression was also observed with 
fibroblasts derived from epithelial tumors. In order to perform this study we generated 
tumors in murine model of breast cancer expressing polyoma middle T antigen under 
the control of MMTV promoter (MMTV-PyMT). Fibroblasts were obtained from these 
tumors as reported in Methods (Herrera et al, 2013). Since these animals also hold 
floxed and deleted Snail1 genes they were transfected with Cre recombinase to 
eliminate Snail1 expression. We chose two cancer-fibroblasts lines, CAF-1857 and 
52149, with high Snail1 expression that were depleted in Snail1 RNA upon Cre 
recombinase transfection (Fig 4A). They were co-cultured with a cell line also 
generated from breast, MCF-7 cells. Both Snail1-depleted CAFs populations showed 
altered PGE2 metabolism with respect to the control since in one case Cox2 was down-
regulated (CAF-52149) whereas the other one (CAF-1857) presented increased levels 
of 15-Hpgd (Fig 4A). Both wild-type CAFs populations significantly enhanced MCF-7 
invasion; this stimulation was abolished by Celecoxib and L-161 indicating that it 
requires PGE2 synthesis and action, and was not observed in the Snail1-depleted CAF 
populations (Fig 4B).     
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Other results obtained with fibroblasts derived from human tumors also showed an 
association between Snail1 levels and invasion. Different populations of colon tumors-
derived fibroblast were used in these assays (Herrera et al., 2013, 2014). Snail1 
expression was analyzed and CAFs were classified as Snail1-high (those showing an 
expression greater than 66% of the average) or Snail1-low (lower than 33% of the 
average). Cox2 RNA expression correlated with that of Snail1 in these cells (Fig. 4C). 
The capability to stimulate HT-29 M6 invasion was also associated to Snail1 
expression since it was higher for Snail1-high than Snail-low populations. Moreover, it 
was sensitive to the addition of SB or Celecoxib to the culture medium (Fig. 4D). 
Finally, Snail1-high CAFs also showed a higher stimulation of PGE2 production by co-
culture with HT-29 M6 cells than Snal1-low CAFs, a stimulation that was sensitive to 
SB (Fig. 4E).    
 
Expression of Snail1 in mesenchymal cells is required for fibroblast-dependent 
enhancement of epithelial tumor invasion in vivo 
 In order to verify the relevance of Snail1 expression in fibroblasts we use mentioned 
murine model of breast cancer by expression of PyMT (MMTV-PyMT). We generated 
murine lines carrying this oncogene, deleted or floxed alleles of Snail1 (also a wild-type 
allele as control) and a Cre recombinase-Estrogen Receptor (Cre-ER) fusion protein 
under the control of the ubiquitous -Actin promoter (-Actin-Cre-ER). In this mice, Cre-
ER was activated and, therefore, Snail1 depleted, by injection of tamoxifen when 
animals where eight weeks-old. Control animals (MMTV-PyMT, -Actin-Cre-ER, 
Snail1+/Flox) developed tumors earlier than mice depleted in Snail1 and presented a 
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lower survival (Fig 5A). Eight weeks after tamoxifen injection in both animal lines tumor 
burden was higher in Snail1 WT than Snail1 KO mice (Fig 5B). 
Animals were euthanized in both cases when tumors reach a pre-specified size and 
tumors were analyzed. As shown in Fig 5C, Snail1 WT but not Snail1 KO mice showed 
Snail1 expression in the nuclei of stromal cells, apparently fibroblasts localized in areas 
of invasion. Snail1 was never detected in tumor epithelial cells. The morphology of the 
tumors was different and Snail1 KO mice originated mostly adenomas, with compact 
glandules and with low presence of stromal cells (Fig 5D). On the contrary, Snail1 WT 
animals developed tumors with features of late carcinomas and with an abundant 
stroma. Snail1 expression also controlled the invasion to lymph nodes, determined 
analyzing the presence of CK19-positive colonies (Figs 5E-F). The percentage of mice 
presenting epithelial cells in the lymph nodes was dependent on Snail1 expression 
since was much higher in Snail1 WT than in Snail1 KO mice. 
To more specifically evaluate the contribution of stromal Snail1 in invasion we used an 
orthotopic implantation model. Epithelial tumor cells were isolated from PyMT tumors 
(ePyMT). In vitro invasion of these cells was also stimulated by co-culture with MSCs 
(Fig S9); this stimulation was inhibited by Celecoxib or SB. As above, Snail1-depleted 
MSCs only very slightly increased ePyMT invasion (Fig S9). ePyMT cells alone or with  
MSCs, either Snail1 WT or KO, were allografted in the mammary fat pad of SCID mice. 
No differences were observed in the growth or volume of the tumors arising in the three 
conditions (Fig 6A). As expected, tumors obtained using control MSCs showed Snail1 
presence in stromal fibroblasts whereas those from Snail1 KO did not (Fig 6B). The 
morphology of these tumors was also different since Snail1 WT tumors presented 
features of an advanced carcinoma, with disorganized epithelial structures and nuclei 
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of different sizes and shapes (Fig 6C). On the other hand, ePyMT/MSC-Snail1 KO co-
xenografts formed tumors with characteristics of adenomas or early carcinomas; thus, 
epithelial structures were clearly delimited and surrounded by a single layer of stromal 
cells (Fig 6C). 
Tumors were resected and mice maintained alive for one more month until metastases 
were apparent. All mice orthotopically injected with ePyMT and Snail1 WT MSCs 
developed lung metastases by this time (Fig 6D-E). Contrarily, mice grafted with 
epithelial cells and Snail1 KO MSCs did not. Curiously, mice transplanted with only 
ePyMT generated metastasis in 50% of the cases (Fig 6D). These results indicate that 
Snail1 expression in tumor fibroblasts is required for tumor invasion and lack of Snail1 
in these cells exerts a protective effect.               
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DISCUSSION 
Here, we describe a new role for Snail1  relevant for cancer progression, since it is 
required for fibroblast activation and for the enhancement of tumor invasion by these 
cells. Snail1 function has been widely studied in EMT. This factor is required for the 
onset of the process, the initial repression of CDH1 and the activation of mesenchymal 
genes (Thiery et al, 2009). EMT and Snail1 are essential for embryonic development; 
however, their contribution to epithelial tumor progression is still a matter of discussion. 
Our analysis of Snail1 expression in human tumors has revealed that, in most 
neoplasms, it is normally expressed in a limited fraction of cells with  fibroblastic 
morphology and located in the stroma, close to the interface with epithelial tumor cells 
(Franci et al, 2009; Stanisavljevic et al, 2015). Therefore, we have investigated the 
function of Snail1 in cancer-associated fibroblasts and its role in epithelial tumor 
invasion.   
Using co-culture models of invasion we demonstrate that mesenchymal cells with 
characteristics similar to cancer-associated fibroblasts stimulate invasion of epithelial 
tumor cells. This stimulation is dependent on signals derived from the epithelial cells of 
the tumor that activate the mesenchymal cell. For most of breast and colon tumor cell 
lines examined, TGF- seems to be the cytokine responsible for this activation, 
although it is possible that other cytokines or growth factors might substitute TGF- in 
other tumors. Snail1 expression in fibroblasts is required for a full transcriptional 
response to TGF- (Batlle et al., 2013). Snail1 is rapidly induced by this cytokine and is 
required for the activation of non-canonical targets such as those commonly used as 
markers for activated fibroblasts or undifferentiated MSCs, two very similar  cellular 
entities. We suggest that the inhibition of the transcriptional activation of TGF--target 
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genes in Snail1 KO cells is likely the consequence of the impaired repression of PTEN 
by this transcriptional factor (Escrivá et al., 2008; Batlle et al., 2013). Although, as 
recently reported by us and other groups (Stanisavljevic et al, 2011; Hsu et al, 2014), 
Snail1 also actively participates in the transcription of mesenchymal genes by binding 
to their promoters. In any case, it is clear that Snail1 is also required for the stimulation 
of MSC migration (Fig 1E). 
The Snail1-dependent transcriptional program triggered by TGF- on mesenchymal 
cells impinges on epithelial invasion on different ways. First, as shown in Fig S4A, it 
induces the transcriptional activation of several matrix protease genes. Since MSCs 
precede epithelial cells when invading through the matrix, it is likely that this high 
expression of proteases helps to degrade the matrix, physically facilitating epithelial cell 
movement. We have also reported that active MSCs also reorganize the extracellular 
matrix enabling directional migration of tumor cells (Stanisavljevic et al, 2015).  
Besides these indirect actions, MSCs secrete signals like PGE2 that actively facilitate 
epithelial migration acting as chemo-attractants. Due to the high instability of this 
molecule, it is likely that this prostaglandin only works at short-range and requires to be 
produced by cells close to the target cells; thus, mesenchymal cells placed in the 
tumor-stroma interface. The association of Cox2 expression and PGE2 levels with 
cancer malignancy has been previously shown (Menter et al, 2010). Actually, PGE2 
contributes to generate cancer stem cells and stimulate their growth (Li et al, 2012, 
Kurtova et al, 2015). Although these effects are associated with an EMT (ref??), we did 
not detect significant morphological alterations in any epithelial cell line after addition of 
PGE2; cells maintain E-cadherin expression and invade collectively (Fig S7). Actually, 
in our model of invasion, MSCs did not cause any significant change in the phenotype 
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of HT-29 M6 cells that migrate through Matrigel in a collective fashion retaining E-
cadherin (Fig 2). 
We also demonstrate a role for Snail1 in cancer invasion. First, the effect of tumor-
derived CAFs on in vitro invasion is associated (for human CAFs) or dependent (for 
murine CAFs) to Snail1 expression and is partially blocked by TBR or PGE2 inhibitors. 
Moreover, Snail1 depletion affects growth and invasion of breast tumors in the PyMT 
mice model and when comparing tumors of the same size. Those tumors from Snail1 
KO mice exhibit a much more differentiated phenotype with fewer areas of invasion 
and lower lymph node micrometastases. Orthotopic xenograft experiments also 
showed similar results, since co-injection of epithelial cells with mesenchymal cells 
depleted for Snail1 originated less advanced and aggressive tumors than when the 
cells were co-xenografted with Snail1 wild-type cells. Lung metastases were also 
dependent on Snail1 expression. Curiously, the number of metastases was higher 
when epithelial cells were injected alone than when cells were injected with Snail1 KO 
MSCs ( Fig 6D), indicating that fibroblasts with loss of Snail1 function protected from 
tumor invasion.  This result is suggesting that Snail1 KO MSCs prevent activation of 
host fibroblast and inhibit tumor invasion, but it is also possible that the higher secretion 
of protease inhibitors by these cells also contributes to this inhibition.    
We think that these results conclusively demonstrate that Snail1 expression is required 
for the activation of CAFs and for the effects of these cells on tumor invasion. This 
agrees with results from our group indicating that Snail1 presence in the stroma 
associates with a bad prognosis (Francí et al, 2009; Stanisavljevic et al, 2015). 
However, this conclusion does not mean that Snail1 expression in epithelial cells is not 
also relevant, since if expressed transiently it also promotes invasiveness in breast 
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tumor models (Tran et al., 2014). Our results also imply that the overall Snail1 
expression in the tumor, considering both epithelial and stromal cells, is not necessarily 
associated with a loss of E-cadherin since, at least in vitro, expression of Snail1 in the 
fibroblasts facilitate invasion of tumor cells without a significant EMT. Our results also   
provide the molecular basis for the association of stromal markers of fibroblast 
activation with bad prognosis, even in low-grade tumors, since these active fibroblasts 
are capable to drive collective invasion of tumoral cells, a type of invasion observed in 
most epithelial neoplasms (ref??).     
Finally, due to the positive effect of cancer-associated fibroblasts on epithelial tumor 
progression and the required expression of Snail1 for their activation, the interference 
of Snail1 action in fibroblasts emerges as putative target for the action of antineoplastic 
drugs. Recent reports have indicated that the block of TGF- receptor might be a 
promising therapy for colon tumors through the inhibition of tumor-triggered activation 
of stromal fibroblasts (Calon et al, 2012).  Drugs targeting Snail1 present two additional 
advantages on TGF-receptor inhibitors: first they would not induce the undesired 
effects of TGF- inhibition on tumor progression, since they prevent the antineoplastic 
action of TGF-b on tumoral cells keeping an intact, not mutated TGF- signaling 
response, and second, because Snail1 interference not just prevent the fibroblast 
activation in response to TGF- but also to all the extracellular factors we have tested. 
Therefore, acting as a more general inhibitor of the stimulation of fibroblasts by 
different tumoral cells.                               
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EXPERIMENTAL PROCEDURES 
Reagents 
The following reagents were used in this work: TGF-PDGF-BB (both 
fromPreprotech, PGE2 (14010, Cayman Chemical Co), SB505124 (SB; S4696, 
Sigma), Celecoxib (Pz0008, Sigma), L-161,982 (L-161; SML-0690, Sigma), 
PF04418949 (PF-044; PZ-0213, Sigma), GM6001 (GM; cc1010, Merck), Crenolanib 
(S3013, Deltaclon), Cell Tracker (C2925, Life Technologies), DAPI (D9542, Sigma) and 
Tamoxifen (T5648, Sigma). The antibodies used were: Snail1 (Franci et al, 2006); E-
Cadherin (610182, Transduction labs), Tubulin (T9026, Sigma), 15-Hpgd (Ab 967332, 
Abcam), CK19 (Ab133496, Abcam), and GFP (Ab 6556, Abcam).  
 
Mice 
Animals were maintained in a specific pathogen free area and fed ad libitum. All the 
procedures were approved by the Animal Research Ethical Committee from the Parc 
de Recerca Biomèdica de Barcelona and by the Generalitat de Catalunya.  We have 
previously described (Batlle et al., 2013) the generation of a murine line with 
Snail1floxed (Snail1Flox) and Snail1 wild-type (Snail1+) or Snail1 deleted (Snail1-) alleles 
and a Cre recombinase-Estrogen Receptor fusion gene under the control of -Actin 
promoter (-Actin Cre-ER). These animals were mated with MMTV-PyMT mice (Guy et 
al, 1992), kindly provided by Dr. Angel Nebreda (IRB, Barcelona). This murine line 
expresses the Polyoma Virus Middle T antigen under the control of the mouse 
mammary tumor virus promoter; female mice develop mammary tumors with lung 
metastases. Depletion of Snail1 in MMTV-PyMT, -Actin Cre-ER, Snail1Flox/- (or Snail1 
Flox/+ as control) was performed by tamoxifen injection (0.2 mg/g) as described (Batlle et 
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al., 2013) in eight weeks-old mice. When the experiment lasted more than four weeks, 
tamoxifen injection was repeated after one month.   
 
Cell Culture  
Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) 
supplemented with 4.5 g/l glucose (Life Technologies), 2 mM glutamine, 56 IU/ml 
penicillin, 56 mg/l streptomycin, and 10% fetal bovine serum (FBS; GIBCO) and 
maintained at 37°C in a humid atmosphere containing 5% CO2. The human colorectal 
HT-29 M6, HCT-116, SW-620, SW-480, Caco-2 or breast cancer BT-474, MCF-7, 
MDA-MB231, SK-BR3, T47D cell lines were obtained from ATCC or our institute cell 
bank. The generation of HT-29 M6 Snail1 cells has been previously reported (Batlle et 
al, 2000).  Mouse embryo fibroblasts (MEFs) and mesenchymal stem cells (MSCs), 
either Snail1+/- (considered Snail1 wild-type) or Snail1-/- (Snail1 KO) were previously 
established in our laboratory from the Snail1Flox/- mice (Batlle et al, 2013; Millanes-
Romero et al, 2013) by transfection of a plasmid encoding the Cre recombinase or a 
control vector 
 
Generation and culture of human and murine Cancer-Associated Fibroblasts 
(CAF) and epithelial PyMT tumor cells (ePyMT).  
CAFs: Fresh colon tumor samples were obtained from the Puerta de Hierro University 
Hospital of Majadahonda. Informed written consent was obtained from all participants 
after an explanation of the nature of the study, as approved by the Research Ethics 
Board of Puerta de Hierro Majadahonda University Hospital. Tissue samples were cut 
into small pieces of approximately 2–3 mm3 in size and seeded in FCS medium with 
22 
 
 
 
 
200 u/ml penicillin, 200 g/ml streptomycin, 100 g/ml gentamicin, and 2.5 g/ml 
amphotericin B. When outgrowths of fibroblasts appeared, the culture medium was 
replaced by FMB (Lonza) supplemented with FGM-2 Bulletkit (Lonza) to facilitate 
fibroblast growth. The remnants of the tissue were carefully washed away, and CAFs 
were routinely maintained in FBM medium at 37ºC in a humid atmosphere containing 
5% CO2. When CAFs reached 70% confluence cells were expanded and cultured in 
complete medium. Sixteen CAFs populations were analyzed for Snail1 expression; 
those four with the highest and the lowest Snail1 expression were considered as 
Snail1-high and Snail1-low human CAFs and used for further assays. Mouse cancer 
associated fibroblasts were isolated u s i n g  t h e  s a m e  p r o c e d u r e  f r o m  
MMTV-PyMT tumors. Cells were isolated from Snail1Flox/- animals mice in order to 
obtain MSC Snail1-KO. For this, cells were infected with pMX-Cre retrovirus or the 
corresponding control and selected with puromycin for 48 hours.  
ePyMT: Epithelial cells were isolated from breast tumors from MMTV-PyMT mice 
model  using the mouse tumor dissociation kit (MACS, Miltenyi Biotech) to obtain a 
single cell suspension. Cells were then incubated with the mouse epithelial cell 
enrichment kit (STEMCELL Technologies) to eliminate all but epithelial cells; this kit 
consists in a cocktail of biotinylated monoclonal antibodies against CD45, TER119, 
CD31 and BP-1 followed by a combination of two mouse lgG monoclonal antibodies 
against biotin and dextran. After incubation with these antibodies cells are mixed with a 
suspension of magnetic dextran iron particles and finally with a magnet for 5 min. 
Epithelial unbound cells were collected and seeded in EpiCult™-B (Mouse) 
(STEMCELL Technologies} supplemented with EGF (10 ng/mL), FGF (10 ng/mL), 
Heparin (4 g/mL) and FBS (2%). Cells were maintained at 37 °C in 5% CO2 no more 
than a week. 
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Invasion Assay 
Transwells (3442, Costar) were coated with 50 L of Matrigel (0.5g/L) (354230, 
Corning) or Collagen 1 (3 g/l) (354249, Corning) and incubated for 2h at 37 °C. For 
single cells invasion, 0.5-1 x 105 epithelial cells or 2 x 104  fibroblast were seeded on a 
Matrigel-coated transwell in DMEM plus FBS (0.1%) and BSA (0.1%) in a final volume 
of 150 L. In co-culture experiments RFP-labelled epithelial cells (0.5-1 x 105) and 
GFP-labelled fibroblasts (1/10) were mixed, centrifuged at 300 x g for 5 min, 
resuspended in 150 L on the same medium and seeded on Matrigel- or Collagen 1-
coated transwells. After 4h at 37 °C, DMEM plus FBS (10%) was added to the lower 
chamber. At this point, the indicated treatment was added at both chambers except 
PGE2, and PDGF-BB, which were added in to the bottom chamber. The invasion was 
stopped at 48h (epithelial cells) or 24h (fibroblasts); culture medium was kept for other 
analyses and cells were washed with PBS and fixed with 4% p-formaldehyde for 20 
min. Cells at the upper side of the transwell membrane were removed with a cotton 
swab and the membrane with the invading cells was stained with DAPI and mounted 
for microscopy analysis. Five random photos (4x) of each membrane were taken to 
analyze the number of invading cells or the area of invasion in the case of cells that 
invade in colonies. Only RFP or GFP-labelled cells were analyzed in the co-culture 
invasion experiments. Alternatively, ePyMT cells were labelled with CellTracker™ 
Green CMFDA dye (Thermo Fisher; C2925) according to the manufacturer’s intructions 
before mixing with MSCs. Analysis of invading cells was performed with lmageJ 
software. 
 
Other methods are described in the Supplemental Information   
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Figure Legends 
Figure 1. Mesenchymal cell stimulation of HT-29 M6 invasion is dependent on 
Snail1 and TGF-.  (A-C) HT-29 M6 cells (105), labelled with dsRed were seeded 
alone or with 104 MSCs (A-B) or MEFs (C), either wild-type or KO for Snail1 on 
Matrigel-coated Boyden chambers. When indicated, the TBR inhibitor SB (5 M) was 
added to the cell medium.  Cells were fixed after 48 hours and samples processed as 
indicated in Methods. (D), TGF- was determined in the cell medium of Boyden 
chambers after 48 hours by ELISA (ab119557, Abcam). (E) GFP-labelled MSCs were 
seeded with HT-29 M6 cells or treated with TGF- (5 ng/ml); when SB was also added. 
The values were referred to the invasion of MSCs without supplementation. Graphs 
show the mean ± SEM of at least three independent experiments. * indicates a p < 
0.05; **, a p < 0.01. 
Figure 2. Morphology of the invasion of MSCs/HT-29 M6 co-cultures. Sections of 
co-cultured HT-29 M6 and GFP-labelled MSCs were obtained as indicated in Methods, 
included in paraffin and stained with hematoxilin-eosin (H-E), or analyzed by 
immunohistochemistry with antibodies against GFP, Snail1, E-cadherin and P-Smad2.    
Figure 3. MSCs enhancement of HT-29 M6 invasion is dependent on PGE2.  (A) 
The figure shows the secretion of PGE2 by HT-29 M6 and MSCs (WT or KO for Snail1), 
cultured on Matrigel-coated Boyden chambers and treated with TGF-, SB or 
Celecoxib (1 M) when indicated. PGE2 levels were determined by ELISA (RPN222, 
GE Healthcare Life Science). (B-E) Invasion of HT-29 M6 (B-C) or MSCs (D-E) was 
determined as above either alone or in co-culture with the indicated cells. The following 
reagents were also supplemented to the medium: Celocoxib, SB (see above), L-161 
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(10 M), PF-044 (1 MCrenolanib (1 MPGE2 (100 nM) and PDGF-BB (10 ng/ml). 
Graphs show the mean ± SEM of at least three independent experiments. * indicates a 
p < 0.05; **, a p < 0.01 
Figure 4. Stimulation of epithelial cell invasion by CAFs is associated to Snail1 
expression. Murine CAF-1857 and CAF-52149 were obtained from PyMT breast 
tumors and Snail1 was depleted as indicated in Methods; RNA were obtained and the 
expression of the indicated genes determined by q-RT-PCR (A). The capability of 
these CAFs population to stimulate invasion of breast dsRed-labelled MCF-7 cells was 
determined as above with the indicated additions (B). (C), RNA from four Snail1-high 
and four Snail1-low CAFs obtained from colon tumors was analyzed for SNAIL1, COX2 
and PTGES2 expression by qRT-PCR. The capability of these clones to stimulate 
dsRed-labelled HT-29 M6 invasion was determined as above (D), as well as the 
stimulation by HT-29 M6 of their PGE2 production (E). Graphs show the mean ± SEM 
of three independent experiments. * indicates a p < 0.05; **, a p < 0.01 
Figure 5. Snail1 depletion retards PyMT breast tumor growth and invasion. Murine 
lines were generated holding PyMT, -Actin-Cre-ER and Snail1Flox/- genes (or Snail1 
Flox/+ as control). Snail1 depletion was carried out in eight weeks-old females and mice 
were maintained until they breast tumor reach a 1 cm diameter. The survival of Snail1 
WT and KO animals is shown in A and the tumor burden eight weeks after tamoxifen 
injection in B. Expression of Snail1 protein and hematoxylin-eosin staining of 
representative sections of both type of tumors in C and D, respectively. Presence of 
micrometastases in brachial, axillary, inguinal and sciatic lymph nodes was carried out 
after staining with an anti CK19 antibody. The percentage of Snail1 WT and KO mice 
33 
 
 
 
 
presenting micrometastases is shown in E and a representative staining of one of them 
in F.  
Figure 6. Snail1 expression in MSCs enhances invasion of ePyMT cells in vivo. 5 
x 105 ePyMT and, when indicated, 5 x 105 MSCs (Snail1 WT or KO) were injected into 
the mammary fat pad of a SCID mice. Primary tumors were resected when they 
reached 1 cm-diameter and their volume (A), Snail1 expression (B) and histology (C) 
was analyzed. One month after tumor resection mice were euthanized and presence of 
lung metastases was determined. In D the percentage of mice that developed 
metastases are shown and in E a lung colonized by tumor cells. The arrows indicate 
metastases.              
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